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High-risk surgery represents 12.5% of cases but contributes 80% of deaths in the elderly population. Reduction in
morbidity and mortality by the use of intervention strategies could result in thousands of lives being saved and
savings of up to £400m per annum in the UK. This has resulted in the drive towards goal-directed therapy and
intraoperative flow optimization of high-risk surgical patients being advocated by authorities such as the National
Institute of Health and Care Excellence and the Association of Anaesthetists of Great Britain and Ireland.
Conventional intraoperative monitoring gives little insight into the profound physiological changes occurring as a
result of anesthesia and surgery. The build-up of an oxygen debt is associated with a poor outcome and strategies
have been developed in the postoperative period to improve outcomes by repayment of this debt. New
monitoring technologies such as minimally invasive cardiac output, depth of anesthesia and cerebral oximetry can
minimize oxygen debt build-up. This has the potential to reduce complications and lessen the need for
postoperative optimization in high-dependency areas.
Flow monitoring has thus emerged as essential during intraoperative monitoring in high-risk surgery. However,
evidence suggests that current optimization strategies of deliberately increasing flow to meet predefined targets
may not reduce mortality.
Could the addition of depth of anesthesia and cerebral and tissue oximetry monitoring produce a further
improvement in outcomes?
Retrospective studies indicate a combination of excessive depth of anesthesia hypotension and low anesthesia
requirement results in increased mortality and length of hospital stay.
Near infrared technology allows assessment and maintenance of cerebral and tissue oxygenation, a strategy, which
has been associated with improved outcomes. The suggestion that the brain is an index organ for tissue
oxygenation, especially in the elderly, indicates a role for this technology in the intraoperative period to assess the
adequacy of oxygen delivery and reduce the build-up of an oxygen debt.
The aim of this article is to make the case for depth of anesthesia and cerebral oximetry alongside flow monitoring
as a strategy for reducing oxygen debt during high-risk surgery and further improve outcomes in high-risk surgical
patients.
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Intraoperative hemodynamic optimization in high-risk
surgical patients is becoming a gold standard in
anesthetic practice in the UK [1]. It is clear that
the monitoring standards set by the Association of
Anaesthetists of Great Britain and Ireland, that is, elec-
trocardiography (ECG), pulse oximetry, end tidal carbon
dioxide and non-invasive blood pressure, give little indi-
cation of the adequacy of oxygen delivery (DO2) to the
patient during surgery [2]. The build-up of an oxygen
debt during high-risk surgery, which can lead to an
increase of postoperative complications and mortality,
was considered inevitable [3,4]. Although repayment of
the oxygen debt early in the postoperative period by
goal-directed therapy (GDT) guided by sophisticated
hemodynamic monitoring achieves beneficial outcomes
[5,6], little emphasis has been placed on the potential
role of maintaining DO2 intraoperatively and limiting
build-up of the oxygen debt.
Pulse oximetry and monitoring end tidal carbon diox-
ide concentration, together with invasive arterial and
central venous monitoring, continue to be the linchpin
of conventional monitoring that most anesthetists use
today even for high-risk patients. Advanced hemody-
namic intervention strategies to manage these patients
are evident in only around 10% of patients [7]. Based on
the evidence that high-risk surgical procedures represent
about 12.5% of the global volume of surgery carried out
worldwide, this means that a realistic target of reduction
in mortality from 10% in the control groups to 6% in the
intervention groups could mean that potentially up to
800,000 lives could be saved by hemodynamic interven-
tion strategies [8].
However, the situation may be changing as recent
guidelines from the UK’s National Institute of Health
and Care Excellence (NICE) have emphasized better out-
comes and cost savings from hemodynamic monitoring
by use of oesophageal Doppler monitoring (ODM)
(Deltex Medical Group, Chichester, UK) [1,9]. This has
now been extended to include all flow monitoring
technologies with recent guidelines published on the
management of proximal femoral fractures by the Asso-
ciation of Anaesthetists of Great Britain and Ireland
recommending that we should consider hemodynamic
monitoring, depth of anesthesia (DOA) monitoring and
the use of cerebral oximetry [10]. A recent consensus
statement from the Enhanced Recovery Partnership has
also highlighted the importance of individualized goal-
directed fluid therapy alongside the use of hemodynamic
monitoring stating that ‘all Anaesthetists caring for
patients undergoing intermediate or major surgery
should have cardiac output measuring technologies im-
mediately available and be trained to use them’ [11].
NICE has now extended their guidance to include arecommendation for the use of depth of anesthesia mon-
itoring in these high-risk (elderly) patients [12].
What about the role of combined monitoring?
In a review published in 2010 it was proposed that
hemodynamic monitors combined with the use of depth
of anesthesia and cerebral oximetry monitoring might
further improve outcomes. Although there is limited evi-
dence on the use of combined monitoring, the case for
its use will be made [13].
Cerebral oximetry
It is possible to measure cerebral and tissue oxygenation
(regional oxygen saturation, rSO2) by the use of near in-
frared technology (NIRS) [14]. The Invos cerebral and
tissue oximeter (Invos CTO, Covidien, CO, USA) was
the first available for routine clinical use. Although there
are now four main manufacturers employing this tech-
nology, opinions are still divided as to its place in rou-
tine anesthesia practice [15]. Nevertheless, the cerebral
and tissue oximeter has been proposed as providing an
index of brain and tissue oxygenation. The proposition
that the brain is an index organ [16] is based on the fact
that significant falls in rSO2 predict poor outcomes
(both cerebral and non-cerebral) in both cardiac [17,18]
and non-cardiac surgical patients [19]. Significant rSO2
desaturation may occur in up to 30% of major non-
cardiac surgical procedures in elderly patients [19] and
is usually associated with blood loss [20]. More import-
antly randomized controlled studies suggest that main-
tenance of rSO2 within 10% to 20% of baseline in these
same patient groups reduces complications [16,18].
Although the normal rSO2 in a fit young patient may be
around 60% to 70%, representing a venous weighted
measure of cerebral tissue oxygenation, values as low as
35% are sometimes seen in elderly patients presenting
for surgery and may be a significant predictor of a poor
outcome [21]. A recent study suggests that rSO2 is a
potentially important ‘biomarker to measure in heart
failure patients and suggests that it may be a useful
marker of target organ perfusion’ [22]. What is most in-
teresting is that this monitor provides an early warning
system for picking up imbalances between cerebral oxy-
gen supply and demand, specifically deficient cerebral
oxygen delivery, and if placed over the forehead, acts as
an indicator of ischemia in the watershed area of the
brain – that area supplied by the middle and anterior
cerebral arteries. Other monitors may not identify these
abnormalities [16].
Thus, a pre-induction measure of rSO2 for an elective
patient provides a starting point from which to measure
cumulative oxygen desaturation and also acts as a pre-
dictor of the likelihood of intraoperative and postopera-
tive complications.
Figure 1 Range of propofol requirements in mg.kg-1.hr-1 to
maintain BIS in the 40 to 60 range. Note the nearly fivefold
variation in propofol requirements. BIS: bispectral index.
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Oxygen debt can be assessed by measuring the differ-
ence in oxygen consumption (VO2) intraoperatively and
comparing this value with that obtained in the
immediate preoperative period [3]. However, calculation
of oxygen consumption requires pulmonary artery
catheterization to determine the mixed venous oxygen
content as well as thermodilution to measure cardiac
output (CO) and cannot easily be employed routinely.
An association exists between cumulative oxygen debt
occurring during surgery and the immediate postopera-
tive period with a poor outcome [3,4]. These deleterious
effects may be ameliorated by artificially increasing oxy-
gen delivery to so-called goal-directed therapy (GDT)
targets of 600 ml.min-1.m-2 using inotropes and fluids in
the immediate postoperative period [23]. However, such
aggressive therapy may not be necessary if oxygen
delivery can be maintained and oxygen debt minimized
intraoperatively. The Shoemaker studies indicated that
the build-up of oxygen debt was usually associated with
reduced oxygen delivery intraoperatively. Thus maintai-
ning oxygen delivery seems to be a logical strategy for
the elective patient in order to minimize the build-up of
an oxygen debt. In this context, the cerebral and tissue
oximeter is arguably the best continuous non-invasive
assessment of the adequacy of cerebral and tissue oxy-
genation, especially in elderly, elective surgical patients
[14]. If oxygen delivery is insufficient to supply enough
oxygen for adequate cellular activity then rSO2 will fall
(signifying increased oxygen extraction when supply is
deficient) and should be corrected. A recent review also
suggests that maintaining tissue oxygenation may im-
prove outcomes [14].
Depth of anesthesia monitoring
Awareness
Recent prospective, double-blinded studies have pro-
duced conflicting data on whether or not bispectral
index (BIS) monitoring reduces patient awareness com-
pared with other techniques such as close monitoring of
end tidal anesthetic concentration in (say) the 0.7 to 1.3
minimal alveolar concentration (MAC) range. However,
the trials are plagued with discrepancies in their proto-
cols that render some of the results meaningless [24-26].
Nevertheless, what is clear is that patients who consist-
ently have high BIS numbers are the ones most likely to
be aware [27].
Too deep?
The recommended optimal ranges of maintenance BIS
values are between 40 and 60 [28]. Some evidence points
to an association of excessive depth of anesthesia with
poor outcomes especially in high-risk patients [29-31].
However, not all the data supports this hypothesis[32,33]. Two studies carried out by analyzing retrospect-
ive data of two classes of patients who participated in
the B-unaware study [26] showed conflicting results. A
persistent BIS value below 45 led to a poor outcome in
the cardiac surgical cohort [30]. However, when this
analysis was repeated for the non-cardiac surgical
patients, no difference in outcomes was found [33]. The
proposed explanation for this paradox was ‘that BIS
values lower than 45 are likely markers of systemic ill-
ness, poor cardiac function, or complicated intraope-
rative course,’ which explains the difference in outcomes
for cardiac versus non-cardiac surgical patients [33].
This explanation must be vigorously challenged, as it
seems naïve to assume that all patients have the same
pharmaco-genetic make-up and if BIS is low then the
concentration of anesthetic should be reduced. Our own
data (Figure 1) show a fivefold variation in propofol
requirements to maintain BIS in the 40 to 60 range
(Figure 2) in a series of 103 high-risk, elderly patients.
Without the correct use of depth of anesthesia monitor-
ing it is clear that conventional population-based targets
may lead to many patients being too deeply anesthetized
whilst others will be too light.
Kertai et al. [33] also state that ‘putting these data to-
gether, if the pharmacologically paralyzed patient were
hypotensive and anesthetic was delivered at a clinically
acceptable concentration with BIS values less than 45
(e.g. BIS of 39) the appropriate initial intervention might
not be to decrease anesthesia. Instead, it might be
preferable to treat hypotension with fluids, for example,
or a drug such as norepinephrine or phenylephrine.’
Surely, if the patient were hypotensive with a low BIS
(say 29, but you would need a BIS monitor to know
this), would it not be more appropriate to reduce the
depth of anesthesia first, rather than give more fluids
Figure 2 BIS values obtained for a series of 90 high-risk
patients undergoing major vascular surgery using total
intravenous anesthesia with propofol and remifentanil. The
average BIS was 45 and only 6 patients had BIS maintained below
the normal lower range of 40. BIS: bispectral index.
Figure 3 Possible mechanism of how anesthetic concentration
may affect outcomes. Anesthetic concentration increase along the
x axis. If the concentration is too low then there is a risk of
awareness and lack of neuronal protection (left y axis). If the
concentration is too high then there is a risk of cardiovascular
depression with hypotension and decreased oxygen delivery (DO2)
and a risk of neuronal toxicity (right y axis). The red arc indicates a
low-risk patient where the risk of problems is small despite big
changes in anesthetic concentration. The blue curves indicate the
various likely responses of a high-risk patient where the response to
anesthesia is, and the implications for getting it wrong, are much
greater as indicated by the much steeper dose–response curves. CV:
cardiovascular; DO2: oxygen delivery.
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elderly patients with a high BIS value and here we firstly
need to vigorously treat the causes of hypotension and
then deepen the anesthetic. How can we do that ration-
ally without hemodynamic and BIS monitoring? A re-
cent study supports a very close relationship between
stroke volume and BIS level, which confirms depth of
anesthesia as a potent cause of reduced cardiac output
and oxygen delivery presumably resulting from
propofol-induced venous tone reduction [34]. Hence, for
an elderly high-risk patient this could lead to a decrease
in DO2 and even a build-up of oxygen debt [35]. A con-
flict of rational management occurs here as, although a
recent recommendation by expert authors suggests that
depth of anesthesia monitoring should be used for total
intravenous anesthesia, the same authors also advise that
the concentration of anesthetic should not be adjusted
to keep BIS within the target range [36].
Two recent reviews of the evidence for the effect of
depth of anesthesia on outcomes call for large-scale pro-
spective, randomized controlled trials to be urgently car-
ried out to support or contradict the hypothesis that low
BIS is associated with poor outcomes [37,38]. Looking
specifically at the incidence of delirium and cognition in
the postoperative period in elderly patients, it would ap-
pear from the CODA trial that maintaining BIS in the
40 to 60 range significantly reduces the incidence of
both these complications [39].
Triple low
Retrospective analysis of a large anesthesia database at
the Cleveland Clinic indicates an association between
the cumulative time of being in a triple low state
(low BIS <45, low minimal alveolar concentration, MAC< 0.8, and low mean arterial pressure, MAP < 75 mmHg)
with a fourfold increase in 30-day mortality and in-
creased length of hospital stay [40]. The study empha-
sizes that these values are referenced on patients whose
mean BIS, MAP and MAC values are outside one SD of
their population mean values and not necessarily outside
the range normally tolerated as clinically acceptable by
most anesthetists. Interestingly, low BIS on its own was
not a predictor of poor outcomes in this series, although
in a high-risk patient a low BIS might be associated with
low MAP and low MAC. Low MAP and BIS values in
those receiving low anesthetic MAC may identify pa-
tients who are ‘unusually sensitive to anesthesia and at
risk for complications’ confirmed. Their suggestion that
‘Inadequate cerebral perfusion is perhaps the most inter-
esting putative cause of low BIS because it is potentially
amenable to hemodynamic intervention, such as giving
vasopressors or fluids to improve MAP and brain perfu-
sion’ highlights the potential role of cerebral oximetry
and flow monitoring alongside BIS in these patients [40].
Figure 3 offers an explanation of how low BIS might be
a potential cause of poor outcomes for high-risk/elderly
patients but may be less predictive of outcomes in
healthy patients. It should also be noted that although
the emphasis has been on low BIS as a predictor of out-
comes, a high BIS level may not only lead to awareness
but also result in a lack of neuronal protection and lead
to postoperative cognitive dysfunction [41], itself a cause
of poor outcome [42].
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It is usual anesthetic practice to maintain a patient’s
MAP within 20% of the patient’s baseline value. A com-
mon response to a fall in MAP is to administer fluid,
either crystalloids such as lactated Ringer’s or colloids
such as gelatins or starch. Recent studies, however, have
suggested that some patients receive too much fluid dur-
ing major surgery and a fluid restriction or zero-balance
strategy may lead to better outcomes [43,44]. Most anes-
thetists still employ a maintenance fluid regime based
originally on a paper published in 1961 by Shires et al.
[45], who were the first group to propagate what is now
seen by many as a myth, that is, third-space loss. They
suggested up to 15 ml.kg-1.hr-1 of lactated Ringer’s be
administered to replace the extracellular fluid that had
been presumed lost from the functional extracellular
fluid volume (FECV). This regime may result in a
patient receiving up to an equivalent of 10 days normal
Na+ requirement (700 mmol) in the space of a four-hour
operation. Evidence exists that excess fluid may damage
the glycocalyx and thus exacerbate loss of FECV [46].
This regimen may lead to poorer outcomes in compari-
son with GDT and restrictive regimens in colorectal sur-
gery [47]. Despite this evidence, even the most recent
trials using hemodynamic optimization protocols con-
tinue to presume this third-space loss, with fluid admin-
istered in the control group, and the intervention group,
often amounting to more than 10 ml.kg-1.hr-1 of lactated
Ringer’s or Hartmann’s solution [48,49]. A recent review
of the evidence for third-space loss in surgery or follow-
ing blood loss indicates that it does not occur [50]
(see later).Figure 4 Intraoperative fluid management strategy as proposed by th
FTc: flow-time corrected; SD: stroke distance; SV: stroke volume.Oesophageal Doppler monitoring
The potential for intraoperative hemodynamic monitor-
ing to improve outcome has mainly been derived from
work on oesophageal Doppler monitoring [12-14]. Un-
fortunately the three main studies on which the NICE
guidelines were based used different end points in
assessing the adequacy of optimal hemodynamics.
Gan et al. [51] and Noblett et al. [52] used optimization
of the flow-time corrected value maintained between
350 and 400 ms whilst Wakeling et al. [53] used stroke
volume maximization together with central venous pres-
sure (CVP). The latter study led to the algorithm cur-
rently employed by Deltex (Deltex Medical PLC,
Chichester, UK) the manufacturers of the Doppler moni-
tor, which does not use CVP and flow-time corrected
monitoring (Figure 4). When this algorithm was used in
a recent study employing the ODM the intervention
group actually had worse outcomes [48]. In addition,
using a Doppler monitor to maximize stroke volume
(SV) does not seem to produce any benefits in outcomes
when compared with a restrictive, zero-balance tech-
nique, despite achieving higher nominal cardiac output
in the oesophageal Doppler intervention group [54].
Pulse contour and power analysis
There is surprisingly little data supporting the benefits
of intraoperative (versus postoperative [23]) hemody-
namic optimization using flow monitors, which analyze
the arterial pressure waveform and convert it into flow.
The LiDCOrapid monitor (LiDCO PLC, Cambridge,
UK) analyses the whole arterial waveform and not just
the systolic portion as do other devices and thus itse Deltex company (Deltex Medical, Chichester, UK) [55].
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affected by changes in waveform morphology [56]. Des-
pite some confusion in the literature [57], the algorithm
used in the Rapid is the same as that used for the past
12 years in the LiDCOplus. The difference is that the lat-
ter is a calibrated value of the cardiac output whilst the
Rapid uses the patient’s height, weight and age to scale
the algorithm to produce a nominal cardiac output
(nCO). This is then used as a reference pre-induction
value in elective patients. Recent work suggests that this
monitor is suitable for use for these high-risk patients
[58,59]. The ability of such monitors to obtain a baseline
value of the patient’s hemodynamic status prior to in-
duction is an advantage and allows use of the patient as
their own control, and the monitors are used to main-
tain nCO (and therefore oxygen delivery) close to this
baseline value throughout surgery. Often there may be a
fall in nCO post-induction of up to 50% in elderly pa-
tients with limited cardiac reserve [35]. It is clear that
hemodynamic monitoring commencing post-induction
may greatly underestimate the patient’s starting nCO
and nDO2 values, making it impossible to use the pa-
tient as their own control. In a study by Lobo et al. [49],
patients receiving goal-directed therapy to a target oxy-
gen delivery of 600 ml.min-1.m-2 with dobutamine and
fluids using the LiDCOplus with a restricted background
infusion of LR of 4 ml.kg-1.hr-1 did better than those re-
ceiving the conventional regime of 12 ml.kg-1.hr-1 des-
pite achieving lower goal-directed therapy targets [49].
What about the role of conventional maintenance fluids
given alongside hemodynamic optimization?
The definition of a maintenance fluid in the intraope-
rative period often confuses basic physiological losses
(around 1 to 2 ml.kg-1.hr-1 of crystalloid and around 1
mmol.kg-1 of Na+ per day) with the excess loss due to
third-space fluid loss (up to 15 ml.kg-1.hr-1 or 10 mmol.
kg-1 Na+ per day). Since third-space loss during elective
major surgery is now believed to be minimal [46,50,60]
(see above), this strategy can result in considerable fluid
overload and paradoxically may increase the risk of
acute kidney injury in the perioperative period [61].
Elective patients are not usually fluid depleted; any fall
in SV during the induction of anesthesia is likely due to
alterations in venous capacitance and a fall in venous re-
turn and pre-load, making fluid an inappropriate choice
of treatment in the early stages of anesthesia.
Any strategy that assumes that this loss still takes
place is liable to result in fluid overload and a worsened
outcome [48,49]. Using a stroke volume maximization
strategy in patients in a background of excessive DOA
again may result in excessive fluid administration. Thus,
it would seem rational to base fluid requirement on
hemodynamic monitor data with the patient at theoptimum depth of anesthesia. In the recently completed
Optimise trial the background maintenance fluid was
restricted to 1.5ml.kg-1.hr-1 [62]. Our own data suggest
that optimal hemodynamic targets can be achieved with
substantially reduced amounts of Na+ and fluid given
(crystalloid maintenance), if hemodynamic monitors are
used alongside BIS and a cerebral tissue oximeter [63].
So, should we be employing a stroke volume
maximization strategy?
The stroke volume maximization strategy is based on
the false assumption that the Starling curve applies to an
intact circulation and that the heart is a driver of tissue
oxygenation. The mantra that maximizing CO and DO2
‘must be good for the patient’ has no sound physio-
logical basis and may be deleterious [46]. In fact, it is the
tissues that regulate CO and not the other way round.
So, it is probably unnecessary to try to maximize CO
and DO2 during major surgery. Maintaining pre-
induction DO2 in the intraoperative period seems a
more logical strategy. Trying to drive DO2 to a target of
600 ml.min-1.m-2 in an elderly patient with a Hb of 10 g.
dl-1 would necessitate a 50% increase in CO to achieve
this end point and may impose unnecessary strain on
the cardiovascular system. The ability of the tissues to
regulate their own blood supply and DO2, especially the
brain and muscle, was reviewed by Wolff [64]. A recent
Cochrane review suggests that the benefits of a peri-
operative increase in global blood flow to explicitly de-
fined goals and outcomes following surgery may have
been exaggerated [65].
How do we know that our oxygen delivery is adequate
and how do we avoid a build-up of oxygen debt?
As mentioned earlier, it is very easy for oxygen debt to
build up during major surgery and lead to postoperative
complications. Although postoperative goal-directed
therapy aimed at replacing oxygen debt is beneficial [23],
it may not be required if the accumulation of an oxygen
debt is kept to a minimum in the first instance. A logical
strategy to maintain pre-induction DO2 in elective high-
risk patients intraoperatively would be to use pre-
induction monitoring. In our institution, for example,
this is done by attaining the nCO using a LiDCOrapid
monitor slaved off a radial arterial line before induction
of anesthesia. During surgery nominal nCO and nominal
DO2 (nDO2) are maintained within 10% of pre-
induction values. This is achieved by the judicious use of
vasopressors such as phenylephrine, commenced pre-
induction, to maintain venous tone and venous return
combined with fluid challenges, based on stroke volume
variation (SVV) whilst ensuring optimal depth of
anesthesia [66]. Maintenance of pre-induction values of
rSO2 ensures, as best as we can, that oxygen supply/
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may improve outcomes [14]. Falls in rSO2 are corrected
by restoration of nCO, nDO2, MAP, oxygen saturation
(SpO2) and ensuring normocapnia [19]. If rSO2 con-
tinues to fall then it is usually due to blood loss and
anemia and is correctable by blood transfusion [20].
This strategy has given further insights into the prob-
lems arising when the blood volume is insufficient to fill
the circulatory capacity due to a fall in venous tone. Any
discrepancy between blood volume and circulatory cap-
acity will mean there is a reduced blood volume on the
arterial/capillary side of the circulation. With the in-
creased capacity due to venodilation on induction there
will be a reduction in venous return and thus SV and
CO. Those organs with the most robust auto-regulatory
capacity (heart and skeletal muscle) will sustain normal
blood flow, whereas those with the least will be under-
filled. The gut is the first to exhibit a defective blood
flow, as suggested by gastric tonometry studies [67,68].
The next organ is probably the brain, though renal blood
flow is also compromised with modest reductions in
blood volume (or reduction in the relation of the blood
volume to capacity). With careful responses to increased
SVV (an indicator of excess venous capacity), there will
be a resumption of blood flow to these most vulnerable
organs. Some further work is needed to monitor the spe-
cific organs during assessment of volume status.
Conclusion
Hemodynamic monitoring commenced pre-induction,
together with maintenance of an adequate depth of
anesthesia and cerebral oxygenation, helps to ensure
intraoperative optimization of oxygen delivery. This not
only minimizes or even eliminates any build-up of oxygen
debt but also reduces fluid and sodium input, thus allowing
true individualization of fluid therapy. Large-scale, pro-
spective randomized trials are urgently needed to prove or
disprove that this strategy improves patient outcomes [13].
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